Insurance Daily News

CVS Health Weighs Potential Retail Pharmacy Spin-Off

CVS Health is reportedly exploring a strategic restructuring that could separate its retail pharmacy business from its insurance and pharmacy benefit management (PBM) units. According to a Financial Times report, the company is considering spinning off its retail arm—which includes approximately 9,000 stores—into a separately listed entity. Under this potential arrangement, the remaining company would retain Aetna, the PBM Caremark, and care-delivery businesses acquired in 2023, Signify Health and Oak Street Health.

While the Financial Times cited individuals familiar with the deliberations, Reuters reported that discussions remain at an early stage with no final decisions made. CVS Health did not address the potential separation in its third-quarter earnings release, which was published Wednesday, and the company did not provide comment to the outlets prior to publication. The retail unit is projected to account for roughly one-third of the company's total revenue this year.

Such a move would represent a significant shift from the logic behind the company’s $78 billion acquisition of Aetna in 2018. At the time, leadership argued that integrating pharmacies, clinics, and insurance coverage would effectively lower healthcare costs by directing members to lower-cost care settings like MinuteClinics. If the split proceeds, it would undo the core structure of that merger, though the insurer and PBM would remain joined.

The potential restructuring occurs amid a challenging regulatory environment for companies that simultaneously operate insurers, PBMs, and pharmacies. Several states have moved to restrict such vertical integration. For instance, Tennessee’s FAIR Rx Act, signed in May, prohibits companies from holding more than a 5% stake in a pharmacy while also owning a PBM and a health insurer. CVS has challenged this law in court, warning that it might close all 134 of its Tennessee locations rather than restructure. Arkansas passed similar legislation in April 2025, which is currently facing legal challenges.

Federal scrutiny is also intensifying. Senators Elizabeth Warren and Josh Hawley reintroduced the Patients Before Monopolies Act in May, which would mandate that the parent companies of PBMs or insurers divest from pharmacy businesses. The bill defines "pharmacy" to include mail-order and specialty pharmacies, both of which are operated by Caremark, potentially complicating the impact of a retail-only spin-off. Additionally, new federal rules finalized by the Labor Department now require PBMs to disclose compensation details to large self-insured employer plans.

Financially, the insurance segment has shown improvement. In the third quarter, the Health Care Benefits segment, which includes Aetna, reported $912 million in adjusted operating income, up from $314 million in the same period last year. The medical benefit ratio improved to 91.3% from 92.8%. However, the company is currently engaged in litigation with federal regulators regarding Medicare Advantage star ratings, alleging that calculation methods cost the company more than $2 billion in bonus payments. CVS recently raised its 2026 revenue outlook to at least $420 billion.

For industry stakeholders, this potential separation signals that the regulatory and political pressure on integrated healthcare models is reaching a critical threshold. Whether a retail spin-off would satisfy federal regulators remains uncertain, particularly given that the most controversial aspects of the PBM business model—such as mail-order and specialty pharmacy operations—would likely remain within the parent company.

Why it matters

A potential CVS spin-off highlights the growing regulatory and political risks facing vertically integrated healthcare giants, forcing the industry to re-evaluate the viability of combining insurance, PBM, and retail pharmacy assets.

FAQ

What parts of the business would remain with the parent company if the spin-off occurs?
The remaining company would retain Aetna, the pharmacy benefit manager Caremark, and care-delivery businesses Signify Health and Oak Street Health.

Why is CVS facing pressure to separate its business units?
CVS is facing political and regulatory pressure from state laws, such as those in Tennessee and Arkansas, and federal legislation like the Patients Before Monopolies Act, which seek to restrict companies from owning pharmacies, PBMs, and insurers simultaneously.

How has the Aetna insurance segment performed recently?
In the third quarter, the Health Care Benefits segment reported $912 million in adjusted operating income, nearly triple the $314 million reported in the same quarter of the previous year.

Source: Insurance Business America. See the original source for full details.